International Menopause Market Expected to Reach $27.63 Billion by 2033
The menopause market is projected to increase at a CAGR of 5.10% between 2025 – 2033, with North America making up 4.9% during this period.
menopause money © Jo Panuwat D - stock.adobe.com
The international menopause market is expected to reach $27.6 billion by 2033, according to a recent analysis of Straits Research, a market research company. In 2024, the global menopause market was valued at $17.7 billion.
Menopause begins 12 months after a woman’s final period, typically between age of 45 and 55. It usually lasts seven years but can last up to 14 years.
About 6,000 women enter menopause every day in the United States, according to the Society for Women’s Health Research.
One of the most common symptoms are vasomotor symptoms – experienced by nearly 75% of menopausal women. These include hot flashes and night sweats. Other symptoms include vaginal dryness, mood swings and weight gain, all of which can result in a decline in quality of life.
As a result, about 86.9% of women have used some form of menopause treatment, according to research published in Menopause, creating an opportunity for a large market for supplements, devices and over the counter medications.
“Furthermore, early treatment can reduce the stress of high healthcare expenditure, as women facing vasomotor symptoms lead to an overall burden of USD 660 million globally,” the report states. “In addition, productivity loss accounts for an additional USD 150 million.”
Menopause can also trigger other healthcare concerns such as hypertension (75%) and osteoporosis (30%).
The high cost of menopause drugs and a growing emphasis on personalized medicine have caused women to seek alternate, over the counter treatments.
Despite an interest in finding relief, there is still a high unmet demand in the menopause market, with 75% of women remaining untreated, which may be due to women feeling embarrassed during check-ups, the World Health Organization reports.
Last month prescription discount company GoodRx reported that the cost of menopause therapies has increased 58% since 2014.
Some of the leading players in the global menopause market include Bayer AG, Dr. Reddy’s Laboratories Ltd. and Hikma Pharmaceuticals USA Inc.
Research and Funding Essential to Improving Postpartum Hemorrhage Outcomes
June 23rd 2025Ways health systems can support care teams treating postpartum hemorrhage and the potential impacts of the Trump administration’s diversity, equity and inclusion (DEI) policies, according to Abigail Wooldridge, assistant professor of Industrial and Enterprise Systems Engineering at the University of Illinois.
Read More
U.S. Has Highest Maternal Death Rate Among High-Income Countries, Experts Cite Funding Gaps
June 6th 2025The United States has the highest maternal mortality rate of any high-income country, a crisis perpetuated by the lack of federal funding of pregnancy research, according to a review published in JAMA Health Forum.
Read More
FDA Approves First At-Home Cervical Cancer Screening Device
May 15th 2025Self-collected samples to test for cervical cancer are a step in the right direction when it comes to addressing healthcare barriers, according to Rahma S. Mkuu, Ph.D., M.P.H., assistant professor in the Department of Health Outcomes & Biomedical Informatics at the University of Florida College of Medicine.
Read More
